VVUS Soars Following FDA’s Statement On Qnexa

Shares of VIVUS Inc (NASDAQ: VVUS) soared as high as 23% in pre-market trading after the US regulators commented on its drug Qnexa.

The FDA mentioned today that VVUS weight loss drug Qnexa is effective in helping obese patients shed pounds.

VVUS' shares have gained 15.76% year-to-date and moved up 11.64% over the past week.

VVUS was up 12.68% to $12.00 at 9:33 am.

Read more from Benzinga's Company news.